THE ANALGESIC ACTIVITY OF CROTAMINE, A NEUROTOXIN FROM CROTALUS-DURISSUS-TERRIFICUS (SOUTH-AMERICAN RATTLESNAKE) VENOM - A BIOCHEMICAL AND PHARMACOLOGICAL STUDY
Ac. Mancin et al., THE ANALGESIC ACTIVITY OF CROTAMINE, A NEUROTOXIN FROM CROTALUS-DURISSUS-TERRIFICUS (SOUTH-AMERICAN RATTLESNAKE) VENOM - A BIOCHEMICAL AND PHARMACOLOGICAL STUDY, Toxicon (Oxford), 36(12), 1998, pp. 1927-1937
Crotamine, a 4.88 kDa neurotoxic protein, has been purified to apparen
t homogeneity from Crotalus durissus terrificus venom by gel filtratio
n on Sephadex G-75. When injected (i.p. or s.c.) in adult male Swiss m
ice (20-25 g), it induced a time-dose dependent analgesic effect which
was inhibited by naloxone, thus suggesting an opioid action mechanism
. When compared with morphine (4 mg/kg), crotamine, even in extremely
low doses (133.4 mu g/kg, i.p., about 0.4% of a LD50) is approximately
30-fold more potent than morphine (w/w) as an analgesic. On a molar b
asis it is more than 500-fold more potent than morphine. It is also mu
ch more potent than the lower molecular weight crude fractions of the
same venom. The antinociceptive effects of crotamine and morphine were
assayed by the hot plate test and by the acetic acid-induced writhing
method. Therefore, both central and peripheral mechanisms should be i
nvolved. Histopathological analysis of the brain, liver, skeletal musc
les, stomach, lungs, spleen, heart, kidneys and small intestine of the
crotamine injected mice did not show ally visible lesion in ally of t
hese organs by light microscopy. Since crotamine accounted for 22% (w/
w) of the desiccated venom, it was identified as its major antinocicep
tive low molecular weight peptide component. (C) 1998 Elsevier Science
Ltd. All rights reserved.